Global Retinal Vein Occlusion Treatment Market Report 2024

Retinal Vein Occlusion Treatment Global Market Report 2024 – By Disease Type (Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO)), By Diagnosis (Optical Coherence Tomography, Fundoscopic Examination, Fluorescein Angiography), By Treatment (Anti-Vascular Endothelial Growth Factor (Anti-VEGF), Corticosteroid Drugs, Other Treatments), By End-user (Hospital And Clinics, Research And Academics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Retinal Vein Occlusion Treatment Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Global Retinal Vein Occlusion Treatment Market Infographic

Proud Members Of

checkslacipN checkaoirsN checkscipN

Retinal Vein Occlusion Treatment Market Definition

Retinal vein occlusion (RVO) treatment involves various strategies aimed at managing complications caused by blocked blood vessels in the retina. These treatments typically focus on reducing swelling (edema) and preventing further vision loss.

The main diseases for retinal vein occlusion treatment are central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). Central retinal vein occlusion (CRVO) refers to a blockage of the central vein in the retina, leading to vision loss due to impaired blood flow and potential retinal damage. Diagnosis often involves optical coherence tomography, fundoscopic examination, and fluorescein angiography. Treatments may include anti-vascular endothelial growth factor (Anti-VEGF) agents, corticosteroid drugs, and others. These treatments are utilized by end users such as hospitals, clinics, research institutions, academic facilities, and others.

Retinal Vein Occlusion Treatment Market Segmentation

The retinal vein occlusion treatment market covered in this report is segmented –

1) By Disease Type: Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO)

2) By Diagnosis: Optical Coherence Tomography, Fundoscopic Examination, Fluorescein Angiography

3) By Treatment: Anti-Vascular Endothelial Growth Factor (Anti-VEGF), Corticosteroid Drugs, Other Treatments

4) By End-user: Hospital And Clinics, Research And Academics, Other End-Users

Global Retinal Vein Occlusion Treatment Market Size 2023 to 2028: Graph

Retinal Vein Occlusion Treatment Market Size 2024 And Growth Rate

The retinal vein occlusion treatment market size has grown strongly in recent years. It will grow from $2.11 billion in 2023 to $2.26 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to the adoption of combination therapies targeting multiple aspects of disease pathophysiology, the growing prevalence of diabetes and hypertension expanded access to healthcare services and specialized retinal care, clinical trials demonstrating the efficacy of new treatment modalities, and the development of anti-VEGF therapies.

Retinal Vein Occlusion Treatment Market Growth Forecast

The retinal vein occlusion treatment market size is expected to see strong growth in the next few years. It will grow to $2.97 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to cost-effectiveness and reimbursement policies, patient preferences for non-invasive treatments, increased healthcare spending globally, an increasing aging population, and the development of new drugs and therapies. Major trends in the forecast period include gene therapy advancements, nanotechnology for drug delivery, artificial intelligence (AI) in diagnostics, telemedicine and remote monitoring, and the development of patient-centric technologies.

Retinal Vein Occlusion Treatment Market Driver: The Growing Impact Of Eye Diseases On The Treatment Market

The increasing prevalence of eye conditions is expected to propel the growth of the retinal vein occlusion treatment market going forward. Eye conditions refer to any disorders or diseases affecting the eyes or vision. They can include a range of issues, from minor irritations and infections to more serious conditions like glaucoma, cataracts, macular degeneration, and diabetic retinopathy. The rise in cases of eye conditions is attributed to factors such as aging populations and the increasing prevalence of diabetes and hypertension. Retinal vein occlusion treatment aims to restore blood flow and reduce inflammation to prevent vision loss and manage complications associated with this eye condition. For instance, in January 2024, according to the Centers for Disease Control and Prevention, a US-based science and data-driven service organization that protects the public's health, over 3.4 million Americans aged 40 years and older were blind or visually impaired, which is expected to double by 2030. Therefore, the increasing prevalence of eye conditions is driving the growth of the retinal vein occlusion treatment market.

Global Retinal Vein Occlusion Treatment Market Major Players

Major companies operating in the retinal vein occlusion treatment market are Roche Holding AG, Bayer AG, Novartis International AG, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., Chengdu Kanghong Pharmaceutical Group Co. Ltd., Spark Therapeutics Inc., Genentech Inc., Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Aerpio Pharmaceuticals Inc., REGENXBIO Inc., Stealth BioTherapeutics Corp., Adverum Biotechnologies Inc., Graybug Vision Inc., Oxurion NV, PanOptica Inc., Clearside Biomedical Inc.

Global Retinal Vein Occlusion Treatment Market Trend: Innovations In Retinal Vein Occlusion Treatment To Focus On Interchangeable Biosimilars

Major companies operating in the retinal vein occlusion treatment market are focusing on developing innovative products, such as interchangeable biosimilars, to enhance treatment options and improve patient accessibility. An interchangeable biosimilar is a biologic drug that is highly similar to an existing reference biologic and can be used as an alternative to manage inflammation and fluid leakage effectively. For instance, in May 2024, Biocon Biologics Limited, an India-based biosimilar manufacturing company, received US Food and Drug Administration approval for Yesafili (aflibercept-jbvf), which is an interchangeable biosimilar of EYLEA (aflibercept). It functions as a vascular endothelial growth factor (VEGF) inhibitor, treating various ophthalmic conditions such as neovascular age-related macular degeneration (wet AMD), macular edema secondary to retinal vein occlusion (branch RVO or central RVO), diabetic macular edema (DME), and myopic choroidal neovascularization (myopic CNV).

Retinal Vein Occlusion Treatment Market Merger And Acquisition: Samsung Biologics' Acquisition Of Samsung Bioepis To Boost Biopharmaceutical Capabilities

In April 2022, Samsung Biologics Co. Ltd., a South Korea-based biotechnology company, acquired Samsung Bioepis for $2.3 billion. This acquisition is expected to accelerate Samsung Bioepis' sales growth, operating margins, and capabilities in biosimilar development and novel drug development. Samsung Bioepis Co. Ltd. is a South Korea-based biopharmaceutical company that provides treatment for retinal vein occlusion through its biosimilar product BYOOVIZ (ranibizumab-nuna).

Regional Outlook For The Global Retinal Vein Occlusion Treatment Market

North America was the largest region in the retinal vein occlusion treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal vein occlusion treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the retinal vein occlusion treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The retinal vein occlusion treatment market consists of revenues earned by entities by providing services such as laser therapy, medication administration, and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The retinal vein occlusion treatment market also includes sales of vitrectomy equipment, and optical coherence tomography (OCT) devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The retinal vein occlusion treatment market research report is one of a series of new reports from The Business Research Company that provides retinal vein occlusion treatment market statistics, including retinal vein occlusion treatment industry global market size, regional shares, competitors with a retinal vein occlusion treatment market share, detailed retinal vein occlusion treatment market segments, market trends and opportunities, and any further data you may need to thrive in the retinal vein occlusion treatment industry. This retinal vein occlusion treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Retinal Vein Occlusion Treatment Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $2.26 billion
Revenue Forecast In 2033 $2.97 billion
Growth Rate CAGR of 7.1% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Disease Type: Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO)
2) By Diagnosis: Optical Coherence Tomography, Fundoscopic Examination, Fluorescein Angiography
3) By Treatment: Anti-Vascular Endothelial Growth Factor (Anti-VEGF), Corticosteroid Drugs, Other Treatments
4) By End-user: Hospital And Clinics, Research And Academics, Other End-Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Roche Holding AG, Bayer AG, Novartis International AG, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., Chengdu Kanghong Pharmaceutical Group Co. Ltd., Spark Therapeutics Inc., Genentech Inc., Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Aerpio Pharmaceuticals Inc., REGENXBIO Inc., Stealth BioTherapeutics Corp., Adverum Biotechnologies Inc., Graybug Vision Inc., Oxurion NV, PanOptica Inc., Clearside Biomedical Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Retinal Vein Occlusion Treatment Market Characteristics

    3. Retinal Vein Occlusion Treatment Market Trends And Strategies

    4. Retinal Vein Occlusion Treatment Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Retinal Vein Occlusion Treatment Market Size and Growth

    5.1. Global Retinal Vein Occlusion Treatment Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Retinal Vein Occlusion Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Retinal Vein Occlusion Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Retinal Vein Occlusion Treatment Market Segmentation

    6.1. Global Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Central Retinal Vein Occlusion (CRVO)

    Branch Retinal Vein Occlusion (BRVO)

    6.2. Global Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Optical Coherence Tomography

    Fundoscopic Examination

    Fluorescein Angiography

    6.3. Global Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Anti-Vascular Endothelial Growth Factor (Anti-VEGF)

    Corticosteroid Drugs

    Other Treatments

    6.4. Global Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospital And Clinics

    Research And Academics

    Other End-Users

    7. Retinal Vein Occlusion Treatment Market Regional And Country Analysis

    7.1. Global Retinal Vein Occlusion Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Retinal Vein Occlusion Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Retinal Vein Occlusion Treatment Market

    8.1. Asia-Pacific Retinal Vein Occlusion Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Retinal Vein Occlusion Treatment Market

    9.1. China Retinal Vein Occlusion Treatment Market Overview

    9.2. China Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Retinal Vein Occlusion Treatment Market

    10.1. India Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Retinal Vein Occlusion Treatment Market

    11.1. Japan Retinal Vein Occlusion Treatment Market Overview

    11.2. Japan Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Retinal Vein Occlusion Treatment Market

    12.1. Australia Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Retinal Vein Occlusion Treatment Market

    13.1. Indonesia Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Retinal Vein Occlusion Treatment Market

    14.1. South Korea Retinal Vein Occlusion Treatment Market Overview

    14.2. South Korea Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Retinal Vein Occlusion Treatment Market

    15.1. Western Europe Retinal Vein Occlusion Treatment Market Overview

    15.2. Western Europe Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Retinal Vein Occlusion Treatment Market

    16.1. UK Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Retinal Vein Occlusion Treatment Market

    17.1. Germany Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Retinal Vein Occlusion Treatment Market

    18.1. France Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Retinal Vein Occlusion Treatment Market

    19.1. Italy Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Retinal Vein Occlusion Treatment Market

    20.1. Spain Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Retinal Vein Occlusion Treatment Market

    21.1. Eastern Europe Retinal Vein Occlusion Treatment Market Overview

    21.2. Eastern Europe Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Retinal Vein Occlusion Treatment Market

    22.1. Russia Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Retinal Vein Occlusion Treatment Market

    23.1. North America Retinal Vein Occlusion Treatment Market Overview

    23.2. North America Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Retinal Vein Occlusion Treatment Market

    24.1. USA Retinal Vein Occlusion Treatment Market Overview

    24.2. USA Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Retinal Vein Occlusion Treatment Market

    25.1. Canada Retinal Vein Occlusion Treatment Market Overview

    25.2. Canada Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Retinal Vein Occlusion Treatment Market

    26.1. South America Retinal Vein Occlusion Treatment Market Overview

    26.2. South America Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Retinal Vein Occlusion Treatment Market

    27.1. Brazil Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Retinal Vein Occlusion Treatment Market

    28.1. Middle East Retinal Vein Occlusion Treatment Market Overview

    28.2. Middle East Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Retinal Vein Occlusion Treatment Market

    29.1. Africa Retinal Vein Occlusion Treatment Market Overview

    29.2. Africa Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Retinal Vein Occlusion Treatment Market Competitive Landscape And Company Profiles

    30.1. Retinal Vein Occlusion Treatment Market Competitive Landscape

    30.2. Retinal Vein Occlusion Treatment Market Company Profiles

    30.2.1. Roche Holding AG

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Bayer AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Novartis International AG

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Regeneron Pharmaceuticals Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Bausch Health Companies Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Retinal Vein Occlusion Treatment Market Other Major And Innovative Companies

    31.1. Santen Pharmaceutical Co. Ltd.

    31.2. Chengdu Kanghong Pharmaceutical Group Co. Ltd.

    31.3. Spark Therapeutics Inc.

    31.4. Genentech Inc.

    31.5. Apellis Pharmaceuticals Inc.

    31.6. Alimera Sciences Inc.

    31.7. Ocular Therapeutix Inc.

    31.8. EyePoint Pharmaceuticals Inc.

    31.9. Aerpio Pharmaceuticals Inc.

    31.10. REGENXBIO Inc.

    31.11. Stealth BioTherapeutics Corp.

    31.12. Adverum Biotechnologies Inc.

    31.13. Graybug Vision Inc.

    31.14. Oxurion NV

    31.15. PanOptica Inc.

    32. Global Retinal Vein Occlusion Treatment Market Competitive Benchmarking

    33. Global Retinal Vein Occlusion Treatment Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Retinal Vein Occlusion Treatment Market

    35. Retinal Vein Occlusion Treatment Market Future Outlook and Potential Analysis

    35.1 Retinal Vein Occlusion Treatment Market In 2028 - Countries Offering Most New Opportunities

    35.2 Retinal Vein Occlusion Treatment Market In 2028 - Segments Offering Most New Opportunities

    35.3 Retinal Vein Occlusion Treatment Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Retinal Vein Occlusion Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Retinal Vein Occlusion Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Roche Holding AG Financial Performance
  • Table 76: Bayer AG Financial Performance
  • Table 77: Novartis International AG Financial Performance
  • Table 78: Regeneron Pharmaceuticals Inc. Financial Performance
  • Table 79: Bausch Health Companies Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Retinal Vein Occlusion Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Retinal Vein Occlusion Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Retinal Vein Occlusion Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Retinal Vein Occlusion Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Retinal Vein Occlusion Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Retinal Vein Occlusion Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Roche Holding AG Financial Performance
  • Figure 76: Bayer AG Financial Performance
  • Figure 77: Novartis International AG Financial Performance
  • Figure 78: Regeneron Pharmaceuticals Inc. Financial Performance
  • Figure 79: Bausch Health Companies Inc. Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the retinal vein occlusion treatment market?

Retinal vein occlusion (RVO) treatment involves various strategies aimed at managing complications caused by blocked blood vessels in the retina. These treatments typically focus on reducing swelling (edema) and preventing further vision loss. For further insights on the retinal vein occlusion treatment market, request a sample here

How will the retinal vein occlusion treatment market drivers and restraints affect the retinal vein occlusion treatment market dynamics? What forces will shape the retinal vein occlusion treatment industry going forward?

The retinal vein occlusion treatment market major growth driver - The Growing Impact Of Eye Diseases On The Treatment Market. For further insights on the retinal vein occlusion treatment market, request a sample here

What is the forecast market size or the forecast market value of the retinal vein occlusion treatment market?

The retinal vein occlusion treatment market size has grown strongly in recent years. It will grow from $2.11 billion in 2023 to $2.26 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to the adoption of combination therapies targeting multiple aspects of disease pathophysiology, the growing prevalence of diabetes and hypertension expanded access to healthcare services and specialized retinal care, clinical trials demonstrating the efficacy of new treatment modalities, and the development of anti-VEGF therapies. The retinal vein occlusion treatment market size is expected to see strong growth in the next few years. It will grow to $2.97 billion in 2028 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to cost-effectiveness and reimbursement policies, patient preferences for non-invasive treatments, increased healthcare spending globally, an increasing aging population, and the development of new drugs and therapies. Major trends in the forecast period include gene therapy advancements, nanotechnology for drug delivery, artificial intelligence (AI) in diagnostics, telemedicine and remote monitoring, and the development of patient-centric technologies. For further insights on the retinal vein occlusion treatment market, request a sample here

How is the retinal vein occlusion treatment market segmented?

The retinal vein occlusion treatment market is segmented
1) By Disease Type: Central Retinal Vein Occlusion (CRVO), Branch Retinal Vein Occlusion (BRVO)
2) By Diagnosis: Optical Coherence Tomography, Fundoscopic Examination, Fluorescein Angiography
3) By Treatment: Anti-Vascular Endothelial Growth Factor (Anti-VEGF), Corticosteroid Drugs, Other Treatments
4) By End-user: Hospital And Clinics, Research And Academics, Other End-UsersFor further insights on the retinal vein occlusion treatment market,
request a sample here

Which region has the largest share of the retinal vein occlusion treatment market? What are the other regions covered in the report?

North America was the largest region in the retinal vein occlusion treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the retinal vein occlusion treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the retinal vein occlusion treatment market, request a sample here.

Who are the major players in the retinal vein occlusion treatment market?

Major companies operating in the retinal vein occlusion treatment market are Roche Holding AG, Bayer AG, Novartis International AG, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., Chengdu Kanghong Pharmaceutical Group Co. Ltd., Spark Therapeutics Inc., Genentech Inc., Apellis Pharmaceuticals Inc., Alimera Sciences Inc., Ocular Therapeutix Inc., EyePoint Pharmaceuticals Inc., Aerpio Pharmaceuticals Inc., REGENXBIO Inc., Stealth BioTherapeutics Corp., Adverum Biotechnologies Inc., Graybug Vision Inc., Oxurion NV, PanOptica Inc., Clearside Biomedical Inc. For further insights on the retinal vein occlusion treatment market, request a sample here.

What are the key trends in the retinal vein occlusion treatment market?

Major trend in the retinal vein occlusion treatment market - Innovations In Retinal Vein Occlusion Treatment To Focus On Interchangeable Biosimilars. For further insights on the retinal vein occlusion treatment market, request a sample here.

What are the major opportunities in the retinal vein occlusion treatment market? What are the strategies for the retinal vein occlusion treatment market?

For detailed insights on the major opportunities and strategies in the retinal vein occlusion treatment market, request a sample here.

How does the retinal vein occlusion treatment market relate to the overall economy and other similar markets?

For detailed insights on retinal vein occlusion treatment market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the retinal vein occlusion treatment industry?

For detailed insights on the mergers and acquisitions in the retinal vein occlusion treatment industry, request a sample here.

What are the key dynamics influencing the retinal vein occlusion treatment market growth? SWOT analysis of the retinal vein occlusion treatment market.

For detailed insights on the key dynamics influencing the retinal vein occlusion treatment market growth and SWOT analysis of the retinal vein occlusion treatment industry, request a sample here.